Skip to main content
MBX logo

MBX · MBX Biosciences, Inc.

Track MBX — free
$68.57 +1.49 (+2.22%) At close · Aug 14
Market Cap
$3.30B
Shares
48.16M

Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Past events

Date Event Type
2026-06-12 MBX Virtual Investor Event: Once-Weekly Canvuparatide Presentations at ENDO 2026 Presentation
2026-06-03 Jefferies Global Healthcare Conference Conference
2026-05-11 MBX In-person and Virtual Obesity Day Event
2026-03-11 Barclays 28th Annual Global Healthcare Conference Conference
2026-03-11 2026 Jefferies Biotech on the Beach Summit Event
2026-03-10 The Citizens Life Sciences Conference Conference
2026-03-10 UBS Biotech Summit Miami – Catalyst for Change Event
2026-03-02 TD Cowen's 46th Annual Health Care Conference Conference
2026-02-25 Oppenheimer 36th Annual Healthcare Life Sciences Conference Conference
2026-01-13 44th Annual J.P. Morgan Healthcare Conference Conference
2025-12-02 Piper Sandler 37th Annual Healthcare Conference Conference
2025-11-24 TD Cowen Treatment Advancements in Obesity and Related Disorders Summit Event
2025-11-19 Jefferies Global Healthcare Conference in London Conference
2025-11-12 Stifel Healthcare Conference Conference
2025-11-10 Guggenheim 2nd Annual Healthcare Innovation Conference Conference
2025-09-30 Stifel 2025 Virtual Cardiometabolic Forum Event
2025-09-22 MBX Biosciences Conference Call - Topline Results from Avail Phase 2 Trial Earnings call
2025-06-09 Goldman Sachs 46th Annual Global Healthcare Conference Conference
2025-06-04 Jefferies Global Healthcare Conference Conference
2025-05-21 RBC 2025 Global Healthcare Conference Conference
2025-05-07 The Citizens Life Sciences Conference Conference
2025-04-07 24th Annual Needham Virtual Healthcare Conference Conference
2025-03-03 TD Cowen 45th Annual Healthcare Conference Conference
2025-02-11 Oppenheimer 35th Annual Healthcare Life Sciences Conference (Virtual) Conference
2025-02-10 BIO CEO & Investor Conference Conference

Source: https://mbxbio.com/investors/

Key facts CIK 1776111 CUSIP 55287L101 13F (30d) 175 filings 171 filers Visit website Investor relations